Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Conference

Event
-
April 9, 2025

genOway's presentation on Wednesday, 9 April, 2025 | 2:15 p.m. CEST:

Assessment of translational tumor biology and efficacy in humanized mouse models:

  • Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment
  • Examining the functionality of myeloid cells and their contribution to translatable safety assessment of therapies
  • Showcasing a mouse model expressing human Fc receptors as tools for translational assessment of Fc receptor-targeted therapies

Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Get in touch

Let us know how we can help

Other news & events

5th Fc-Mediated Summit 2025, July 29-31, 2025
Conference
genOway presentation
Event
-
Jul 2025
Read on
genOway Shanghai at BIONNOVA West China Forum 2025
Conference
Event
-
Jul 2025
Read on
genOway Shanghai - Legal letter - Product name change
Intellectual property
Event
-
Jun 2025
Read on
AACR Annual Meeting 2025, Chicago, IL, April 25-30
Conference
genOway presentation
Event
-
Apr 2025
Read on
Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025
Conference
Event
-
Apr 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe